Clinical

Dataset Information

0

Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy in Surveillance Patients with Primary Sclerosing Cholangitis (PSC)


ABSTRACT: Primary objectives: (i) To assess in incidence of biliary malignancy as assessed by surveillance MR/MRCP in patients with PSC with and without response to UDCA(ii) To assess in incidence of colorectal malignancy as assessed by surveillance colonoscopy in patients with PSC with and without response to UDCA Primary endpoints: - any hepatobiliary malignancy including low-grade dysplasia detected by surveillance MRCP- any colorectal malignancy including low-grade dysplasia detected by surveillance colonoscopy

DISEASE(S): Primary Sclerosing Cholangitis With Or Without Concomitant Inflammatory Bowel Disease Included In An Unlimited Surveillance Program For Hepatobiliary And Colorectal Malignancy

PROVIDER: 2534809 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-09-06 | PXD016127 | Pride
2011-12-01 | E-GEOD-26647 | biostudies-arrayexpress
| 2180918 | ecrin-mdr-crc
2017-07-23 | E-MTAB-4054 | biostudies-arrayexpress
2015-09-29 | GSE73487 | GEO
2022-12-31 | GSE171597 | GEO
2018-05-01 | PXD008302 | Pride
2023-01-08 | GSE210647 | GEO
2019-08-19 | PXD009139 | Pride
2011-12-01 | GSE26647 | GEO